NEJM This Week — March 5, 2026

This week, we explore a phase 3 trial of finerenone in type 1 diabetes and chronic kidney disease and guidance on timing of nonculprit-lesion PCI after STEMI. We cover an investigational therapy for Dravet syndrome and neoadjuvant treatment for high-risk intrahepatic cholangiocarcinoma. We review the effects of radiotherapy on normal tissue, a puzzling case of progressive neurologic decline after suspected foodborne illness, and Perspectives on private equity, the AHEAD model, and medical credit cards.

You can listen to NEJM This Week — March 5, 2026 online on Radio and Podcast. Open the player on this page to stream the available audio.

NEJM This Week — March 5, 2026 is an episode from NEJM This Week - Audio Summaries by NEJM Group.

This episode is 22:54 long.

This episode was published on Mar 4, 2026.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from NEJM This Week - Audio Summaries when more episodes are available from the podcast feed.